These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2945414)

  • 1. Clinical acceptability of transdermal clonidine: a large-scale evaluation by practitioners.
    Hollifield J
    Am Heart J; 1986 Oct; 112(4):900-6. PubMed ID: 2945414
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
    Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
    Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin reactions to long-term transdermal clonidine.
    Dick JB; Northridge DB; Lawson AA
    Lancet; 1987 Feb; 1(8531):516. PubMed ID: 2881081
    [No Abstract]   [Full Text] [Related]  

  • 4. Transdermal antihypertensive therapy: clinical and metabolic considerations.
    Weber MA
    Am Heart J; 1986 Oct; 112(4):906-12. PubMed ID: 2945415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
    Lewis GR
    N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transdermal clonidine: a new therapeutic approach in essential hypertension?].
    Groth H; Greminger P; Vetter H; Knüsel J; Baumgart P; Siegenthaler W; Vetter W
    Schweiz Rundsch Med Prax; 1985 Mar; 74(11):265-9. PubMed ID: 3158058
    [No Abstract]   [Full Text] [Related]  

  • 8. Catapres-TTS: a two year posttrial followup.
    Kellaway GS; Lubbe WF
    N Z Med J; 1988 Jun; 101(847 Pt 1):380. PubMed ID: 2970607
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension.
    Breidthardt J; Schumacher H; Mehlburger L
    Clin Auton Res; 1993 Dec; 3(6):385-90. PubMed ID: 8193526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebound hypertension after discontinuation of transdermal clonidine.
    Schmidt GR; Schuna AA
    Clin Pharm; 1988 Oct; 7(10):772-4. PubMed ID: 3233898
    [No Abstract]   [Full Text] [Related]  

  • 11. Rebound hypertension during initiation of transdermal clonidine.
    Stewart M; Burris JF
    Drug Intell Clin Pharm; 1988; 22(7-8):573-4. PubMed ID: 3416742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
    Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
    Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG; Jain AK; Vargas R; Fillingim J
    Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The USA experience with the clonidine transdermal therapeutic system.
    Burris JF
    Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal clonidine for the treatment of essential hypertension.
    McChesney JA; Ryan C; Shaw RE; Fishman-Rosen J; Murphy MC
    Compr Ther; 1987 Apr; 13(4):49-53. PubMed ID: 3568603
    [No Abstract]   [Full Text] [Related]  

  • 16. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC; Herron J; Zellner S
    Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal clonidine: therapeutic considerations.
    Sica DA; Grubbs R
    J Clin Hypertens (Greenwich); 2005 Sep; 7(9):558-62. PubMed ID: 16227779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides.
    Polster AM; Warner MR; Camisa C
    Cutis; 1999 Mar; 63(3):154-5. PubMed ID: 10190065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
    Davies SF; Graif JL; Husebye DG; Maddy MM; McArthur CD; Path MJ; O'Connell MB; Iber C; Davidman M
    Arch Intern Med; 1989 Jul; 149(7):1551-6. PubMed ID: 2525897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM; Matzek KM; Hughes EM; Johnson PA; Sharon GS
    Clin Ther; 1989; 11(3):398-408. PubMed ID: 2743374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.